Another Twist in the Chronicles of Avandia!

Another Twist in the Chronicles of Avandia!

MEwens

Avandia’s back in the spotlight again, thanks to a Time magazine story that says the company’s under investigation for holding back data from the FDA.

Read more this great post here

Posted in diabetes, Drugs, FDA, Congress

No comments yet. Be the first.

Leave a reply

 
Google
Web ekstrapalma.com

RSS Health Care Blog News